Improving Target Definition for Head and Neck Radiotherapy: A Place for Magnetic Resonance Imaging and 18-Fluoride Fluorodeoxyglucose Positron Emission Tomography?

Robin Prestwich; Jonathan R Sykes; B. Carey; Mehmet Sen; Karen Dyker; Andrew Scarsbrook

doi:https://doi.org/10.1016/j.clon.2012.04.002

doi.org/10.1016/j.clon.2012.04.002

Improving Target Definition for Head and Neck Radiotherapy: A Place for Magnetic Resonance Imaging and 18-Fluoride Fluorodeoxyglucose Positron Emission Tomography?

,

,

..., Andrew Scarsbrook

29

Clinical Oncology3.40

Volume: 24, Issue: 8, Pages: 577 - 589

Published: Oct 1, 2012

Abstract

Defining the target for head and neck radiotherapy is a critical issue with the introduction of steep dose gradients associated with intensity-modulated radiotherapy. Tumour delineation inaccuracies are a major source of error in radiotherapy planning. The integration of 18-fluoride fluorodeoxyglucose positron emission tomography (18FDG-PET) and magnetic resonance imaging directly into the radiotherapy planning process has the potential to...